HAMP and hepatitis C virus infection: Although Flisiak et al. have shown that serum hepcidin levels tend to decrease in hepatitis C patients after DAA treatment [39], most studies reported to date have shown that HCV infection acts in a suppressive manner on hepcidin expression [15–18] and that chronic HCV infection leads to reduced hepcidin level in patients’ sera [40–46].